Aspirin may up cancer survival by 20 per cent

London, April 24: Taking a low-dose of aspirin is likely to increase the survival of patients receiving cancer treatment by up to 20 percent as well as stop their cancer from spreading, says a new research. Researchers found a significant reduction in mortality and spread of cancer in patients who took a low-level dose of aspirin in addition to their cancer treatment.

“Our review, based on the available evidence, suggests that low-dose aspirin taken by patients with bowel, breast or prostate cancer, in addition to other treatments, is associated with a reduction in deaths of about 15-20 percent, together with a reduction in the spread of the cancer,” said lead research Peter Elwood, professor at Cardiff University in Britain.

For the study, published in the jourl PLOS ONE, the team conducted a review, of the available data including five randomised trials and forty-two observatiol studies of colorectal, breast and prostate cancers. “There is a growing body of evidence that taking aspirin is of significant benefit in reducing some cancers,” Elwood said

“Whilst we know a low-dose of aspirin has been shown to reduce the incidence of cancer, its role in the treatment of cancer remains uncertain,” he added. (IANS)